Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,JAK-STAT signaling pathway,0.0003078220110298473,7.262867647058823,58.72746665552502,"['SOCS3', 'CDKN1A', 'EGF', 'OSMR', 'GFAP', 'IL13RA1']",0.03577046166669988,0,0,6
2,NF-kappa B signaling pathway,0.0008734679825620507,7.439498432601881,52.39667822063205,"['GADD45B', 'IL1R1', 'GADD45A', 'PRKCQ', 'ICAM1']",0.03577046166669988,0,0,5
3,Breast cancer,0.0011043281782181493,5.602746212121212,38.14639906453287,"['CDKN1A', 'GADD45B', 'GADD45A', 'EGF', 'WNT7B', 'HES5']",0.03577046166669988,0,0,6
4,MAPK signaling pathway,0.0012303392183005246,3.721816449666561,24.93790219869786,"['EFNA1', 'GADD45B', 'EGF', 'GADD45A', 'IL1R1', 'IL1RAP', 'MAP3K6', 'HSPA1B', 'HSPA1A']",0.03577046166669988,0,0,9
5,Basal cell carcinoma,0.0013435937790428388,9.304109589041095,61.52256244851977,"['CDKN1A', 'GADD45B', 'GADD45A', 'WNT7B']",0.03577046166669988,0,0,4
6,FoxO signaling pathway,0.0013709849503278774,5.357336956521739,35.31677520200737,"['CDKN1A', 'GADD45B', 'BCL6', 'GADD45A', 'EGF', 'IRS2']",0.03577046166669988,0,0,6
7,Complement and coagulation cascades,0.0015748001991628877,15.184948979591837,97.99799479111185,"['C1R', 'PROS1', 'SERPING1']",0.03577046166669988,0,0,3
8,Melanoma,0.002915696673018569,7.395392278953922,43.171685793052355,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.05794947137624406,0,0,4
9,Endometrial cancer,0.004182971439195915,6.637964774951076,36.35436348640737,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.07389916209246117,0,0,4
10,Thyroid cancer,0.004906606533871821,9.711020408163265,51.635172698107624,"['CDKN1A', 'GADD45B', 'GADD45A']",0.07537817211358937,0,0,3
11,Staphylococcus aureus infection,0.005214842095908698,23.0,120.8936688057782,"['C1R', 'ICAM1']",0.07537817211358937,0,0,2
12,Gastric cancer,0.00599739788323379,4.636755485893417,23.72363296939183,"['CDKN1A', 'GADD45B', 'GADD45A', 'EGF', 'WNT7B']",0.07643856914044564,0,0,5
13,Cushing syndrome,0.006848440300528861,4.482758620689655,22.340878102702682,"['CDKN1A', 'RASD1', 'WNT7B', 'PDE8B', 'LDLR']",0.07643856914044564,0,0,5
14,Glioma,0.007313287291051803,5.603684459140293,27.559269887514553,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.07643856914044564,0,0,4
15,Non-small cell lung cancer,0.0077351288817620175,5.508242396099373,26.780981621990147,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.07643856914044564,0,0,4
16,Transcriptional misregulation in cancer,0.008110108507647974,4.292558983666062,20.667143490381857,"['CDKN1A', 'BCL6', 'GADD45B', 'GADD45A', 'NUPR1']",0.07643856914044564,0,0,5
17,Pancreatic cancer,0.008172677203695446,5.415981735159817,26.034400719510057,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.07643856914044564,0,0,4
18,NOD-like receptor signaling pathway,0.008797817014221422,4.203341628154995,19.89547371731124,"['IFI16', 'NAMPT', 'TXNIP', 'GBP2', 'GBP1']",0.07771405029228923,0,0,5
19,Cytokine-cytokine receptor interaction,0.009581836007991,5.1567732115677325,23.968094300176038,"['IL1R1', 'IL1RAP', 'OSMR', 'IL13RA1']",0.0801848381721352,0,0,4
20,Small cell lung cancer,0.010603880704856464,4.997260273972603,22.72021994222764,"['CDKN1A', 'GADD45B', 'COL4A1', 'GADD45A']",0.0843008516036089,0,0,4
21,Antigen processing and presentation,0.011544893394954462,6.930612244897959,30.921010183723926,"['CIITA', 'HSPA1B', 'HSPA1A']",0.08515480876252324,0,0,3
22,Toxoplasmosis,0.012264958245352684,4.775584206285254,21.017389099108456,"['CIITA', 'LDLR', 'HSPA1B', 'HSPA1A']",0.08515480876252324,0,0,4
23,Colorectal cancer,0.01285355603962615,4.705975779233671,20.49045277336804,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A']",0.08515480876252324,0,0,4
24,Osteoclast differentiation,0.01285355603962615,4.705975779233671,20.49045277336804,"['SOCS3', 'IL1R1', 'JUNB', 'FOSL2']",0.08515480876252324,0,0,4
25,Protein digestion and absorption,0.015156125179734825,6.217687074829932,26.04807062019152,"['COL27A1', 'COL4A1', 'KCNJ13']",0.0963929561431135,0,0,3
26,p53 signaling pathway,0.021639833620331214,5.3859410430839,20.64549430522132,"['CDKN1A', 'GADD45B', 'GADD45A']",0.1306062354641024,0,0,3
27,Cell cycle,0.022178417342960787,3.955562980287337,15.065298201321037,"['CDKN1A', 'GADD45B', 'GADD45A', 'CDC7']",0.1306062354641024,0,0,4
28,Epstein-Barr virus infection,0.025076704483125708,3.1769935344827585,11.70981351248193,"['CDKN1A', 'GADD45B', 'GADD45A', 'CD44', 'ICAM1']",0.13444141993849465,0,0,5
29,Hematopoietic cell lineage,0.02517344133345259,8.936186186186186,32.90273152287472,"['IL1R1', 'CD44']",0.13444141993849465,0,0,2
30,Adipocytokine signaling pathway,0.025366305648772576,5.048044217687075,18.548198154523615,"['SOCS3', 'IRS2', 'PRKCQ']",0.13444141993849465,0,0,3
31,Proteoglycans in cancer,0.02727606195643307,3.103448275862069,11.177831833023125,"['CDKN1A', 'CAV3', 'WNT7B', 'PLCE1', 'CD44']",0.13989980164751153,0,0,5
32,Calcium signaling pathway,0.028808553484794008,3.056261343012704,10.840812469783275,"['ITPKC', 'OXTR', 'PLN', 'EGF', 'PLCE1']",0.14314250012757024,0,0,5
33,Th17 cell differentiation,0.035314070100854085,4.4029684601113175,14.721209723968302,"['IL1R1', 'PRKCQ', 'IL1RAP']",0.17014961048593333,0,0,3
34,Hepatitis C,0.04177172571900463,3.2062932320629325,10.181698259269556,"['SOCS3', 'CDKN1A', 'EGF', 'LDLR']",0.1941583486195879,0,0,4
35,Inflammatory mediator regulation of TRP channels,0.04347731209870392,4.034353741496599,12.649780859012584,"['IL1R1', 'PRKCQ', 'IL1RAP']",0.1941583486195879,0,0,3
36,Cholesterol metabolism,0.043960380819529334,6.43027027027027,20.091163959365844,"['ANGPTL4', 'LDLR']",0.1941583486195879,0,0,2
37,Bladder cancer,0.04696452229073497,6.1824324324324325,18.908121409309764,"['CDKN1A', 'EGF']",0.1965094485322858,0,0,2
38,Type II diabetes mellitus,0.04696452229073497,6.1824324324324325,18.908121409309764,"['SOCS3', 'IRS2']",0.1965094485322858,0,0,2
39,Chronic myeloid leukemia,0.05249711949464828,3.7224489795918365,10.970045892344736,"['CDKN1A', 'GADD45B', 'GADD45A']",0.21402671793971992,0,0,3
40,MicroRNAs in cancer,0.05647292121348553,2.8886986301369864,8.302102606720636,"['EFNA1', 'CDKN1A', 'IRS2', 'CD44']",0.224479861823605,0,0,4
41,AGE-RAGE signaling pathway in diabetic complications,0.058308036146243934,3.5573229291716686,10.109966383313678,"['COL4A1', 'PLCE1', 'ICAM1']",0.22612140846958012,0,0,3
42,TNF signaling pathway,0.06440927420486608,3.4061511928715147,9.341361631258147,"['SOCS3', 'JUNB', 'ICAM1']",0.23477118599818164,0,0,3
43,Pathways in cancer,0.0651473196953595,1.942488262910798,5.305137691620724,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'COL4A1', 'WNT7B', 'HES5', 'IL13RA1']",0.23477118599818164,0,0,8
44,Ferroptosis,0.06644467528250424,5.0206925675675675,13.613033671425512,"['CP', 'SLC39A14']",0.23477118599818164,0,0,2
45,Legionellosis,0.06644467528250424,5.0206925675675675,13.613033671425512,"['HSPA1B', 'HSPA1A']",0.23477118599818164,0,0,2
46,Hepatocellular carcinoma,0.06869747100719369,2.6942922374429226,7.215430176946837,"['CDKN1A', 'GADD45B', 'GADD45A', 'WNT7B']",0.23745430195964773,0,0,4
47,Various types of N-glycan biosynthesis,0.07344128405379217,4.72456279809221,12.337104602022766,"['CHST9', 'MAN1C1']",0.24845030137346713,0,0,2
48,Cortisol synthesis and secretion,0.08066259234107824,4.461336336336337,11.231326565650633,"['PDE8B', 'LDLR']",0.2617418812700294,0,0,2
49,Other types of O-glycan biosynthesis,0.08066259234107824,4.461336336336337,11.231326565650633,"['ST6GAL1', 'GALNT16']",0.2617418812700294,0,0,2
50,Lipid and atherosclerosis,0.08394573466625603,2.5044069236487205,6.204880288564424,"['LDLR', 'HSPA1B', 'ICAM1', 'HSPA1A']",0.2669474362386942,0,0,4
51,Longevity regulating pathway,0.08673560017257294,2.983119173595364,7.293400820250942,"['IRS2', 'HSPA1B', 'HSPA1A']",0.26738358891071107,0,0,3
52,Pertussis,0.08809340398135508,4.225817923186344,10.266022966175447,"['C1R', 'SERPING1']",0.26738358891071107,0,0,2
53,Insulin resistance,0.08912786297023702,2.9464907914385265,7.123681514285477,"['SOCS3', 'IRS2', 'PRKCQ']",0.26738358891071107,0,0,3
54,"Growth hormone synthesis, secretion and action",0.09646876010284598,2.8417767106842735,6.645597291240909,"['SOCS3', 'IRS2', 'JUNB']",0.28404690474726874,0,0,3
55,Signaling pathways regulating pluripotency of stem cells,0.10149570928645679,2.7759793572601454,6.350715557111876,"['WNT7B', 'SMAD9', 'ID3']",0.2934148686644842,0,0,3
56,ECM-receptor interaction,0.10749268719928269,3.732872407291012,8.32554649820378,"['COL4A1', 'CD44']",0.30144008255535504,0,0,2
57,PI3K-Akt signaling pathway,0.1088901923148859,2.0416231278300243,4.527126390060398,"['EFNA1', 'CDKN1A', 'EGF', 'COL4A1', 'OSMR']",0.30144008255535504,0,0,5
58,Glycosaminoglycan biosynthesis,0.11149984693162457,3.647727272727273,8.002136267577237,"['HS3ST3B1', 'CHST6']",0.30144008255535504,0,0,2
59,Fluid shear stress and atherosclerosis,0.11185512497337075,2.6530612244897958,5.811665313572186,"['CAV3', 'IL1R1', 'ICAM1']",0.30144008255535504,0,0,3
60,Nitrogen metabolism,0.11758239271195008,8.882923191648024,19.01492730263444,['CA1'],0.3053660442589622,0,0,1
61,Primary bile acid biosynthesis,0.11758239271195008,8.882923191648024,19.01492730263444,['CYP39A1'],0.3053660442589622,0,0,1
62,N-Glycan biosynthesis,0.11962850405681355,3.4885428907168037,7.4074468667218305,"['ST6GAL1', 'MAN1C1']",0.3053660442589622,0,0,2
63,Human T-cell leukemia virus 1 infection,0.12099409300826805,2.1793780081451315,4.602875889638201,"['ZFP36', 'CDKN1A', 'IL1R1', 'ICAM1']",0.3053660442589622,0,0,4
64,PPAR signaling pathway,0.1237469094238708,3.414031052328925,7.133675417767744,"['FABP5', 'ANGPTL4']",0.307433728099929,0,0,2
65,Influenza A,0.12811128849560036,2.487691984010099,5.111848678682425,"['SOCS3', 'CIITA', 'ICAM1']",0.3097050402652674,0,0,3
66,Primary immunodeficiency,0.12855680916671477,7.993959731543624,16.398684108926275,['CIITA'],0.3097050402652674,0,0,1
67,Amoebiasis,0.14054644981824407,3.145204027556969,6.1715735698291105,"['IL1R1', 'COL4A1']",0.32984043981751926,0,0,2
68,Human papillomavirus infection,0.1410638358968007,1.8686143039591316,3.6597610054166885,"['CDKN1A', 'EGF', 'COL4A1', 'WNT7B', 'HES5']",0.32984043981751926,0,0,5
69,Inositol phosphate metabolism,0.15344894633273418,2.96971971971972,5.566405118625821,"['ITPKC', 'PLCE1']",0.3535997458971701,0,0,2
70,African trypanosomiasis,0.16067317140011905,6.147651006711409,11.240260397114831,['ICAM1'],0.3649576321802704,0,0,1
71,Malaria,0.1711151422840423,5.708053691275167,10.077104169991495,['ICAM1'],0.37982242024086527,0,0,1
72,Cellular senescence,0.1719950582222786,2.1517857142857144,3.787765871939187,"['CDKN1A', 'GADD45B', 'GADD45A']",0.37982242024086527,0,0,3
73,TGF-beta signaling pathway,0.1754249904629751,2.716903344021988,4.728889086455256,"['SMAD9', 'ID3']",0.3820900477207266,0,0,2
74,Systemic lupus erythematosus,0.1814280612245701,5.327069351230425,9.092753690886987,['C1R'],0.3898251585771168,0,0,1
75,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.19786129884798914,2.503589527027027,4.056288223792823,"['EGF', 'PRKCQ']",0.419465953557737,0,0,2
76,Shigellosis,0.20866652387898696,1.7380229544613106,2.7235130469449595,"['IL1R1', 'PLCE1', 'PRKCQ', 'CD44']",0.4365523328520911,0,0,4
77,Porphyrin and chlorophyll metabolism,0.2116082533349885,4.438105891126026,6.892460888244535,['CP'],0.4369573023410802,0,0,1
78,Prostate cancer,0.21605028418094954,2.3555246422893483,3.609238738513346,"['CDKN1A', 'EGF']",0.44041019467655096,0,0,2
79,Galactose metabolism,0.22142061582240036,4.204168138466973,6.338587084184561,['GALK1'],0.4426224531403338,0,0,1
80,Kaposi sarcoma-associated herpesvirus infection,0.22270312107689752,1.8802614795918366,2.823994217694542,"['ZFP36', 'CDKN1A', 'ICAM1']",0.4426224531403338,0,0,3
81,cAMP signaling pathway,0.22924872324566528,1.8510204081632653,2.726456321580951,"['OXTR', 'PLN', 'PLCE1']",0.4500067530377874,0,0,3
82,ErbB signaling pathway,0.23898379450242707,2.1932617549055906,3.139346125149568,"['CDKN1A', 'EGF']",0.45557828497316816,0,0,2
83,Starch and sucrose metabolism,0.2406828675329945,3.8031319910514543,5.416706251648291,['GYG2'],0.45557828497316816,0,0,1
84,Ovarian steroidogenesis,0.2406828675329945,3.8031319910514543,5.416706251648291,['LDLR'],0.45557828497316816,0,0,1
85,Mucin type O-glycan biosynthesis,0.2501357187096836,3.6299572910311166,5.030219245887946,['GALNT16'],0.46739825602302976,0,0,1
86,Phosphatidylinositol signaling system,0.2528066038866702,2.106152204836415,2.89623412204693,"['ITPKC', 'PLCE1']",0.46739825602302976,0,0,2
87,Focal adhesion,0.2591123283217576,1.729848774041991,2.3361497177192314,"['CAV3', 'EGF', 'COL4A1']",0.4681688659449939,0,0,3
88,Rap1 signaling pathway,0.2591123283217576,1.729848774041991,2.3361497177192314,"['EFNA1', 'EGF', 'PLCE1']",0.4681688659449939,0,0,3
89,Vascular smooth muscle contraction,0.2666497026636588,2.0256585699623675,2.6775549110497314,"['ACTA2', 'PRKCQ']",0.47396862512686483,0,0,2
90,Nicotinate and nicotinamide metabolism,0.26869214158486615,3.326901565995526,4.372177474863927,['NAMPT'],0.47396862512686483,0,0,1
91,HIF-1 signaling pathway,0.2712650621795264,2.000168918918919,2.6095380753553465,"['CDKN1A', 'EGF']",0.47396862512686483,0,0,2
92,Phagosome,0.2851042025421492,1.927385216541843,2.4186767540035823,"['COLEC12', 'C1R']",0.4874638836263581,0,0,2
93,Endocytosis,0.2868569608274112,1.4987837664831647,1.8716385748350974,"['CAV3', 'LDLR', 'HSPA1B', 'HSPA1A']",0.4874638836263581,0,0,4
94,Measles,0.2897126901062501,1.9042792792792793,2.359146036409474,"['HSPA1B', 'HSPA1A']",0.4874638836263581,0,0,2
95,Ras signaling pathway,0.29285385115661694,1.612381865497877,1.980136494615003,"['EFNA1', 'EGF', 'PLCE1']",0.4874638836263581,0,0,3
96,Estrogen signaling pathway,0.29431781652912187,1.8817170111287758,2.3015188312666863,"['HSPA1B', 'HSPA1A']",0.4874638836263581,0,0,2
97,Protein processing in endoplasmic reticulum,0.3030455785655403,1.58015574650913,1.8865037969588836,"['MAN1C1', 'HSPA1B', 'HSPA1A']",0.4967448143497001,0,0,3
98,Relaxin signaling pathway,0.3172717203099113,1.7764264264264265,2.0393316938005,"['ACTA2', 'COL4A1']",0.5147571788701621,0,0,2
99,Viral myocarditis,0.32166839870873276,2.660178970917226,3.017265652339761,['ICAM1'],0.516618943380692,0,0,1
100,Glycosphingolipid biosynthesis,0.3301193602097702,2.574150248971639,2.85293327529817,['A4GALT'],0.5248897827335346,0,0,1
101,Sphingolipid metabolism,0.34670879046180203,2.417734390888753,2.5610336821907356,['UGCG'],0.5404578204257502,0,0,1
102,Rheumatoid arthritis,0.34670879046180203,2.417734390888753,2.5610336821907356,['ICAM1'],0.5404578204257502,0,0,1
103,Thyroid hormone signaling pathway,0.3581144940409845,1.6137046137046136,1.6571173471853575,"['PLN', 'PLCE1']",0.5495192309443402,0,0,2
104,Apoptosis,0.3626026115536002,1.5974324324324325,1.6205117822066115,"['GADD45B', 'GADD45A']",0.5495192309443402,0,0,2
105,Regulation of lipolysis in adipocytes,0.3628900581707907,2.279194630872483,2.310317855536287,['IRS2'],0.5495192309443402,0,0,1
106,Bile secretion,0.37083075830192863,2.215697240865026,2.1979927066087797,['LDLR'],0.556246137452893,0,0,1
107,Glycerolipid metabolism,0.37867313989946705,2.155632142209323,2.093295299686851,['PLPP4'],0.5627012078879932,0,0,1
108,Amino sugar and nucleotide sugar metabolism,0.38641841231953294,2.0987283645355,1.9955433914767966,['GALK1'],0.5688937736926457,0,0,1
109,Insulin signaling pathway,0.40678239233426594,1.450982800982801,1.3051255104637067,"['SOCS3', 'IRS2']",0.5889051342530399,0,0,2
110,Proteasome,0.40908344626047977,1.9446717957112456,1.7382178899517036,['PSMB9'],0.5889051342530399,0,0,1
111,cGMP-PKG signaling pathway,0.4111224522143863,1.4377891404918433,1.2779992532974844,"['PLN', 'IRS2']",0.5889051342530399,0,0,2
112,Oxytocin signaling pathway,0.4154470675404558,1.4248310810810811,1.2515717176692347,"['CDKN1A', 'OXTR']",0.5897864619547543,0,0,2
113,Notch signaling pathway,0.4519483046874932,1.69555904612309,1.3465917589969696,['HES5'],0.6256751971928892,0,0,1
114,Autophagy,0.45362926371908063,1.317846772392227,1.0417249462225484,"['IRS2', 'PRKCQ']",0.6256751971928892,0,0,2
115,Arrhythmogenic right ventricular cardiomyopathy,0.45878583132536277,1.6600950782997763,1.293499230873165,['DSC2'],0.6256751971928892,0,0,1
116,Th1 and Th2 cell differentiation,0.4655386139716072,1.6260786193672099,1.2432350498907194,['PRKCQ'],0.6256751971928892,0,0,1
117,Spliceosome,0.4660423558890952,1.2856364428945075,0.9815561127592979,"['HSPA1B', 'HSPA1A']",0.6256751971928892,0,0,2
118,Non-alcoholic fatty liver disease,0.470143317023661,1.2752432432432432,0.9624486486569959,"['SOCS3', 'IRS2']",0.6256751971928892,0,0,2
119,Prion disease,0.4703328915582589,1.1839765609213984,0.893090752775015,"['CAV3', 'HSPA1B', 'HSPA1A']",0.6256751971928892,0,0,3
120,Prolactin signaling pathway,0.47220769599463336,1.5934228187919464,1.1956030718915143,['SOCS3'],0.6256751971928892,0,0,1
121,Chemical carcinogenesis,0.4823334925966627,1.2450380067567568,0.9077815024454202,"['BCL6', 'EGF']",0.633810126635284,0,0,2
122,Dilated cardiomyopathy,0.5226681912931402,1.372714649386716,0.8906288635891731,['PLN'],0.6756442472813764,0,0,1
123,Natural killer cell mediated cytotoxicity,0.5226681912931402,1.372714649386716,0.8906288635891731,['ICAM1'],0.6756442472813764,0,0,1
124,Renal cell carcinoma,0.5517411681538997,1.2632363907531692,0.7512166682769301,['CDKN1A'],0.702821838143803,0,0,1
125,Gap junction,0.5628715770667686,1.2241610738255033,0.7035299983408717,['EGF'],0.702821838143803,0,0,1
126,Melanogenesis,0.5628715770667686,1.2241610738255033,0.7035299983408717,['WNT7B'],0.702821838143803,0,0,1
127,Human cytomegalovirus infection,0.5662503974256183,1.0604504504504504,0.6030982140343607,"['CDKN1A', 'IL1R1']",0.702821838143803,0,0,2
128,Leukocyte transendothelial migration,0.5683333912029046,1.20551149074639,0.6811707430624621,['ICAM1'],0.702821838143803,0,0,1
129,Aldosterone synthesis and secretion,0.579054470420366,1.1698578760363205,0.6391620623963382,['LDLR'],0.702821838143803,0,0,1
130,T cell receptor signaling pathway,0.579054470420366,1.1698578760363205,0.6391620623963382,['PRKCQ'],0.702821838143803,0,0,1
131,Bacterial invasion of epithelial cells,0.579054470420366,1.1698578760363205,0.6391620623963382,['CAV3'],0.702821838143803,0,0,1
132,Glycerophospholipid metabolism,0.5895110059962441,1.1362416107382551,0.6004603881143004,['PLPP4'],0.7047537590481414,0,0,1
133,Morphine addiction,0.5895110059962441,1.1362416107382551,0.6004603881143004,['PDE8B'],0.7047537590481414,0,0,1
134,Cell adhesion molecules,0.5946421027183393,1.1201436808772096,0.5822457146280042,['ICAM1'],0.7055827935239996,0,0,1
135,Circadian entrainment,0.6047139326037323,1.0892709386779442,0.547903033198068,['RASD1'],0.7069817300293635,0,0,1
136,"Parathyroid hormone synthesis, secretion and action",0.6047139326037323,1.0892709386779442,0.547903033198068,['CDKN1A'],0.7069817300293635,0,0,1
137,Choline metabolism in cancer,0.6288190642630688,1.0190156599552573,0.4727333073559902,['EGF'],0.729797308159328,0,0,1
138,Apelin signaling pathway,0.6888195495370361,0.8629267580974613,0.3216783370674819,['ACTA2'],0.789773702464126,0,0,1
139,AMPK signaling pathway,0.696564835571726,0.8444238183635585,0.3053389259827221,['IRS2'],0.789773702464126,0,0,1
140,Tuberculosis,0.696564835571726,0.8444238183635585,0.3053389259827221,['CIITA'],0.789773702464126,0,0,1
141,Neuroactive ligand-receptor interaction,0.700365358788942,0.835464500176616,0.2975533042405531,['OXTR'],0.789773702464126,0,0,1
142,Purine metabolism,0.7078251243658338,0.8181000484328513,0.282701192657837,['PDE8B'],0.7925647519307576,0,0,1
143,Phospholipase D signaling pathway,0.7256771793223911,0.777668114225556,0.24935929608981186,['EGF'],0.8068718287570642,0,0,1
144,Adrenergic signaling in cardiomyocytes,0.7456746571867386,0.7340914740243599,0.21543080796890549,['PLN'],0.8155434583099199,0,0,1
145,Wnt signaling pathway,0.7488638044858384,0.727295117295733,0.2103324013107813,['WNT7B'],0.8155434583099199,0,0,1
146,Hippo signaling pathway,0.7488638044858384,0.727295117295733,0.2103324013107813,['WNT7B'],0.8155434583099199,0,0,1
147,Hepatitis B,0.7786494064048239,0.6656138965653375,0.16653286307960044,['CDKN1A'],0.8395066933278041,0,0,1
148,Tight junction,0.7814276139151888,0.6600111856823266,0.16278037900877165,['YBX3'],0.8395066933278041,0,0,1
149,mTOR signaling pathway,0.789556104550569,0.6437496589730998,0.15210799188850066,['WNT7B'],0.8425464471378554,0,0,1
150,Ubiquitin mediated proteolysis,0.8049230541352455,0.6134956557931429,0.13313382788342257,['SOCS3'],0.8532184373833602,0,0,1
151,Viral carcinogenesis,0.8168734733413234,0.5903536011219073,0.11941145074388394,['CDKN1A'],0.8592772279250946,0,0,1
152,Pathogenic Escherichia coli infection,0.82144741285921,0.5815732333201737,0.1143881022307397,['IL1R1'],0.8592772279250946,0,0,1
153,Coronavirus disease,0.8446486744370123,0.5375519335250879,0.09075731620946972,['C1R'],0.8687117594558914,0,0,1
154,Regulation of actin cytoskeleton,0.8485330706068566,0.5302463852979595,0.08709096429000648,['EGF'],0.8687117594558914,0,0,1
155,Axon guidance,0.8504389328088573,0.5266666666666666,0.08532140685421026,['EFNA1'],0.8687117594558914,0,0,1
156,Diabetic cardiomyopathy,0.8523209715416293,0.523134361527179,0.08359273608412159,['PLN'],0.8687117594558914,0,0,1
157,Alzheimer disease,0.866659181221547,0.5659634454598483,0.08099473479193987,"['WNT7B', 'IRS2']",0.8776994255683183,0,0,2
158,Herpes simplex virus 1 infection,0.946603960437529,0.4254363355180794,0.023345596690557486,"['SOCS3', 'ZNF442']",0.9525951247440957,0,0,2
159,Pathways of neurodegeneration,0.9904136983854075,0.21248506021881033,0.0020467721132300686,['WNT7B'],0.9904136983854075,0,0,1
